Evidence check: ApoB in the context of allergy

ApoB (apolipoprotein B) is a core protein of LDL particles and a well-established risk marker for cardiovascular disease. In the context of allergy, however, there is no robust evidence supporting ApoB as a direct biomarker or causal factor. Some mechanistic studies suggest a possible link between lipid metabolism and immune regulation – for example, oxidized LDL may influence inflammatory pathways. But these connections remain speculative and lack clinical validation. Commercial tests offering ApoB as part of allergy panels are therefore best classified as marketing. For allergy diagnosis, IgE antibodies, skin prick tests, and oral food challenges remain the gold standard. ApoB measurement belongs in cardiovascular risk assessment, not allergology. Consumers should be cautious about overinterpreting such biomarkers without clear evidence.